Print

Endocyte, Inc. (ECYT) Announces Second Quarter 2013 Earnings Conference Call  
7/19/2013 9:56:29 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WEST LAFAYETTE, Ind., July 18, 2013 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy in cancer and other serious diseases, today announced that the company will host a conference call on Thursday, Aug. 1, at 4:30 p.m. EDT to discuss its second quarter 2013 financial results and provide an operational update.

Help employers find you! Check out all the jobs and post your resume.

//-->